胱抑素C诊断早期糖尿病肾病的临床意义(2)
![]() |
第1页 |
参见附件。
[参考文献]
[1] Suh DC,Kim CM,Choi IS,et al.Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus,1988 to 1994 to 1999 to 2004[J].J Am Geriatr Soc,2008, 56(3):484-492.
[2] Trivedi H,Pang M,Campbell A,et al.Slowing the progression of chronic renal failure: economic benefits and patients’perspectives[J].Am J Kidney Dis,2002,39(4):721-729.
[3] Ozden TA,Tekerek H,Bas F,et al.Effect of Hypo -and euthyroid status on serum Cystatin C Levels [J].J Clin Res Pediatr Endocrinol,2010,2(4):155-158.
[4] Johe GT,Fleming JJ,Talaulikar GS,et al.Measurement of renal function in kidney do-nors usingserum cystatinC and beta[J].Ann Clin Biochem,2003,40(6):656-658.
[5] Suzuki Y, Matsushita K.Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes[J].Clin Chem Lab Med,2012,50(10):1833-1839.
[6] Krolewski AS,Warram JH.Serum concentration of cystatin C and risk of end-stage renal disease in diabetes[J].Diabetes Care,2012,35(11):2311-2316.
[7] Astor BC, Shafi T, Hoogeveen RC,et al.Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.[J].Am J Kidney Dis,2012,59(5):653-662.
[8] Sahakyan K,Lee KE,Shankar A,et al,Serum cystatin C and the incidence of type 2 diabetes mellitus[J].Diabetologia,2011,54(6):1335-1340.
(收稿日期:2013-02-25)
您现在查看是摘要介绍页,详见PDF附件。